ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Caribou Biosciences Announces Closing of Upsized Initial Public Offering
July 28, 2021Caribou Biosciences, Inc., (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the closing of its previously announced initial public offering of 19,000,000 shares of common stock, at a price to the pu
Pharma Sources Insight January 2025
